{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:52:08Z","timestamp":1761511928212},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[1994,1,1]],"date-time":"1994-01-01T00:00:00Z","timestamp":757382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1016\/0959-8049(94)00253-2","type":"journal-article","created":{"date-parts":[[2004,4,17]],"date-time":"2004-04-17T23:13:19Z","timestamp":1082243599000},"page":"1474-1478","source":"Crossref","is-referenced-by-count":7,"title":["Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study"],"prefix":"10.1016","volume":"30","author":[{"given":"A.","family":"Veronesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"CriveUari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Magri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Delia","family":"Valentina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Foladore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.G.","family":"Trovo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Nascimben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sibau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Talamini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Monfardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0959-8049(94)00253-2_BIB1","first-page":"315","article-title":"Recent developments in chemotherapy treatment of small-cell lung cancer","volume":"20","author":"Johnson","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/0959-8049(94)00253-2_BIB2","first-page":"479","article-title":"Cisplatin and VP-16-213 combination chemotherapy for refractory small cell carcinoma of the lung","volume":"69","author":"Porter","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/0959-8049(94)00253-2_BIB3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/07357908809077023","article-title":"Cisplatin and etoposide as second-une chemotherapy in patients with small cell lung cancer","volume":"6","author":"Figoli","year":"1988","journal-title":"Cancer Invest"},{"key":"10.1016\/0959-8049(94)00253-2_BIB4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1200\/JCO.1985.3.11.1471","article-title":"VP-16 and Cisplatin as first-line therapy for small-cell lung cancer","volume":"3","author":"Evans","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(94)00253-2_BIB5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00257447","article-title":"Combination chemotherapy with cisplatin and etoposide associated with radiotherapy in the treatment of small cell lung cancer","volume":"24","author":"Figoli","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/0959-8049(94)00253-2_BIB6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.7326\/0003-4819-107-4-451","article-title":"Superiority of alternating non-cross resistant chemotherapy in extensive small cell lung cancer","volume":"107","author":"Evans","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/0959-8049(94)00253-2_BIB7","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","article-title":"Does thoracic irradiation improve survival and local control in limited- stage small-cell carcinoma of lung? A meta-analysis","volume":"10","author":"Warde","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(94)00253-2_BIB8","first-page":"338","article-title":"Prophylactic cranial irradiation in small-cell lung cancer","volume":"20","author":"Harris","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/0959-8049(94)00253-2_BIB9","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/0959-8049(92)90065-A","article-title":"Epirubicin in previously untreated patients with small cell lung cancer: a phase II study by the EORTC lung cancer cooperative group","volume":"28A","author":"Quoix","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/0959-8049(94)00253-2_BIB10","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1985.3.6.818","article-title":"A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer","volume":"3","author":"Jain","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(94)00253-2_BIB11","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1200\/JCO.1984.2.4.294","article-title":"Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung","volume":"2","author":"Feld","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(94)00253-2_BIB12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/0959-8049(94)00253-2_BIB13","first-page":"125","article-title":"Statistical Methods in Medical Research","author":"Armitage","year":"1987"},{"key":"10.1016\/0959-8049(94)00253-2_BIB14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimations from incomplete observations","volume":"53","author":"Kaplan","year":"1978","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/0959-8049(94)00253-2_BIB15","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/0959-8049(94)00253-2_BIB16","first-page":"127","article-title":"Long term survival in small cell lung cancer: the Italian experience","volume":"2","author":"Rosti","year":"1991","journal-title":"Cancer Ther Control"},{"key":"10.1016\/0959-8049(94)00253-2_BIB17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/bjc.1989.52","article-title":"High dose etoposide for brain metastases of small cell lung cancer. A phase II study","volume":"59","author":"Postmus","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/0959-8049(94)00253-2_BIB18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1200\/JCO.1992.10.2.282","article-title":"Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group","volume":"2","author":"Roth","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/0959-8049(94)00253-2_BIB19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jnci\/83.12.855","article-title":"Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer","volume":"83","author":"Fukuoka","year":"1991","journal-title":"J Natl Cancer Inst"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804994002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0959804994002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T07:27:47Z","timestamp":1550042867000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0959804994002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["0959804994002532"],"URL":"https:\/\/doi.org\/10.1016\/0959-8049(94)00253-2","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}